ULUR
vs
S&P 500


Over the past 12 months, ULUR has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's 10% growth.
Stocks Performance
ULUR vs S&P 500
Performance Gap
ULUR vs S&P 500
Performance By Year
ULUR vs S&P 500
ULURU Inc
Glance View
ULURU, Inc. is a pharmaceutical company, which engages in the development and commercialization of wound care and muco-adhesive film products. The company is headquartered in Addison, Texas. The company went IPO on 2002-07-17. The firm is a specialty medical technology company that is involved in developing and commercializing wound care and drug delivery systems based on its patented technologies. Its patented technology platforms include Altrazeal and OraDisc. Altrazeal is a new class of material designed to optimize the wound bed environment and accelerate healing. When applied to a moist wound, the powder interacts with wound exudate and hydrates. OraDisc is a novel, patented, water-erodible pharmaceutical carrier device, the multi-layered device may be applied to mucosal surfaces, and adheres immediately, delivering actives to treat specific localized diseases/disorders. OraDisc technology can deliver drugs systemically across the mucosal surface or for the release of drugs into the oral cavity. The device causes minimum discomfort and provides tailored erosion rates to deliver therapeutics over different time intervals.
